This inventor holds 3 USPTO granted patents. Top assignee: Laboratoires Jacques Logeais. Active years: 1980-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1983
Title: Pierre P Delaunay: Innovator in Pharmaceutical Compositions
Introduction
Pierre P Delaunay is a notable inventor based in Herblay, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address circulatory insufficiencies. With a total of 3 patents to his name, Delaunay's work has the potential to impact therapeutic practices.
Latest Patents
Delaunay's latest patents include innovative compositions that are therapeutically useful. One of his notable inventions is the compound described as (5-Aminomethyl)-4,5,6,7-tetrahydro[d]thiazole containing compositions. This invention relates to compounds of the formula (I), where R is selected from hydrogen and C1-6 alkyl, and R' is also selected from hydrogen and C1-6 alkyl. These compounds, along with their pharmaceutically acceptable acid addition salts, are aimed at treating circulatory insufficiencies. Another significant patent involves 4,5 or 6-Alkylaminoalkyl-2-alkyl-4,5,6,7-tetrahydro benzo[d]thiazoles, which shares a similar formula and therapeutic application.
Career Highlights
Pierre P Delaunay is associated with Laboratoires Jacques Logeais, where he has been instrumental in advancing pharmaceutical research. His work has garnered attention for its potential to improve treatment options for patients suffering from circulatory issues.
Collaborations
Delaunay has collaborated with notable colleagues such as Jacques G Maillard and Jacky M Legeai. These partnerships have contributed to the development of innovative solutions in the pharmaceutical industry.
Conclusion
Pierre P Delaunay stands out as an inventor whose work in pharmaceutical compositions has the potential to enhance therapeutic practices. His contributions are significant in addressing critical health issues, particularly circulatory insufficiencies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile